In conclusion, in the murine model of allergic asthma used herein, both BMMC and MSC administration were effective in reducing airway inflammation and remodeling and improving lung function. However, the improvement in lung mechanics and histology was more evident after BMMC administration, suggesting that the interaction between the multiple cell types

present in the bone marrow mononuclear fraction plays an important role in these processes. These observations have several implications for the framework of future clinical studies, due to the aforementioned advantages of BMMCs over MSCs. The authors would like to express their gratitude to Mr. Andre Benedito da Silva for animal care, Dr. Bruno Paredes for his help with flow cytometry analysis, Mrs. Ana Lucia Neves da Silva for her help with microscopy, Vemurafenib price and Mrs. Moira Elizabeth Schöttler and Ms. Claudia Buchweitz for their assistance this website in editing the manuscript. Financial support: This study was supported by the Centres of Excellence Program (PRONEX-FAPERJ), Brazilian Council for Scientific and Technological Development (CNPq), Rio de Janeiro State Research Foundation (FAPERJ), Coordination for the Improvement of Higher Education Personnel (CAPES), INCT-INOFAR, Coordination Theme 1 (Health) of the European Community’s FP7 (TARKINAID). “
“Rabies is a neglected zoonotic disease that causes severe

and long-lasting societal and economic burdens. Its implications are especially apparent in poverty-stricken less-developed countries, and are a significant public health threat for two-thirds

of the world’s population, being endemic across most of Africa Benzatropine and Asia (Fooks, 2005 and Hampson et al., 2008). Rabies is generally considered to be a fast-moving transboundary disease that does not respect borders and is the most important human zoonosis causing tens of thousands of deaths per year, mostly in children (Rupprecht et al., 2008 and WHO, 2005). The case fatality rate of human rabies is the highest of all infectious diseases; once clinical disease develops, the resulting illness is almost uniformly lethal. Insufficient financial resources, a weak health care infrastructure and inadequate reporting systems all contribute to under-reporting of the disease. In addition, more rigorous public disclosure is urgently needed to determine the true global burden of rabies (Fooks, 2005 and Knobel et al., 2007). This lack of empirical data has been a principal cause of the low prioritization of rabies control in endemic countries (Rupprecht et al., 2008). In this article, we review obstacles to the elimination of canine rabies in resource-limited countries, and establish the critical role of validated diagnostic tests and surveillance systems in the management of rabies. Our paper forms part of a symposium in Antiviral Research on the global elimination of canine rabies.